Company news
Emvision Medical Devices Ltd. (ASX:EMV) news
Emvision Medical Devices Ltd. news releases on 6ix. Latest, Nov 15, 2023: AGM CEO Presentation including Latest Imaging Case Studies
Press releases — page 2
AGM CEO Presentation including Latest Imaging Case Studies
November 14, 2023
AGM Chairman's Address
November 14, 2023
Gen 2 Advanced Prototype Assembled
October 23, 2023
Encouraging Interim Clinical Trial Results
October 9, 2023
Appendix 4E & Annual Report to 30 June 2023
August 29, 2023
Latest Imaging and Clinical Trial Insights
August 21, 2023
Clinical Trial Progress & ASA Milestone Achieved
July 26, 2023
Recruitment at Royal Melbourne Hospital Commences
June 28, 2023
$1.75M Manufacturing Grant Payment Received
June 12, 2023
Leadership Transition
May 30, 2023
Stage 2 of Clinical Trial Activated
May 28, 2023
Product Development Milestones & Grant Funding Achieved
April 16, 2023
CEO Half-Year Update
February 27, 2023
Clinical Trial Stage 1 Enrolment Completed
February 20, 2023
Trial Progressing on Target and ASA Milestone Achieved
January 24, 2023
$8.8m In Non-Dilutive Funding To Be Received This Quarter
November 30, 2022
EMVision Commences Clinical Trial
November 29, 2022
AGM Chairman Address and Presentation
November 15, 2022
Portable Brain Scanner Delivered to First Clinical Site
November 13, 2022
EMVision Backed By NSW Medical Devices Fund With $2.5m Grant
November 10, 2022
$5m Modern Manufacturing Initiative Funding Agreement Signed
October 24, 2022
Ethics Approval Received For Multi-Centre Clinical Trial
October 3, 2022
Employee Incentive Plan Issue
September 16, 2022
Appendix 4E & Annual Report to 30 June 2022
August 29, 2022
$5m Modern Manufacturing Initiative Grant Proceeding
August 28, 2022
Centres of Excellence Confirmed as First Two Clinical Sites
July 11, 2022
EMVision Achieves First Responder Milestone
June 26, 2022
EMVision Awarded $5m Non-Dilutive Funding via MMI Grant
May 17, 2022
Pause in Trading
May 16, 2022
EMVision Secures Strategic Agreement With Keysight
May 4, 2022
New Appointments to Clinical Advisory Board
March 8, 2022
S&P DJI Announces March 2022 Quarterly Rebalance
March 4, 2022
EMvision Medical Devices : Application for quotation of securities - EMV
December 22, 2021
EMV Technology to be Presented at Prestigious Conference
December 8, 2021
EMVision Receives $3.4m Non-Dilutive Funding this Quarter
December 7, 2021
EMvision Medical Devices : Notification regarding unquoted securities - EMV
December 1, 2021
Clinical Trial Data Drives Confidence for Expanded Studies
November 29, 2021
AGM Chairmans Address & Presentation
November 25, 2021
EMvision Medical Devices : AGM Chairman's Address & Presentation
November 24, 2021
FDA Breakthrough Device Application Update
October 5, 2021
ASA & EMVision Sign $8m Project Agreement
September 15, 2021
Appendix 4E & Annual Report 30 June 2021
August 31, 2021
1st Gen Device Successfully Manufactured & Ready for Testing
August 9, 2021
EMVision 1st Generation Device Progressing Well
July 19, 2021
Clinical Research Partnership Signed with Metro South Health
June 20, 2021
Appendix 4C - quarterly
April 29, 2021
S&P DJI Announces March 2021 Quarterly Rebalance
March 12, 2021
Successful MRFF Bid
March 1, 2021
Half Year Report & CEO Update
February 24, 2021
EMVision Reports Very Encouraging Pilot Clinical Trial Data
October 27, 2020